A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Not...
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fea...
Henry Schein delivered a positive second quarter, with results exceeding Wall Street’s expectations and earning a strong market response. Management attribut...
Dental and medical products company Henry Schein (NASDAQ:HSIC) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 6.7% year on ...
What Happened? Shares of dental and medical products company Henry Schein (NASDAQ:HSIC) jumped 2.8% in the afternoon session after the company reported secon...
Henry Schein (NASDAQ:HSIC) reported higher second-quarter sales, operating margins and earnings, citing accelerating internal sales growth, market-share gains in dental merchandise and early benefits from its value-creation program. The company also raised its full-year sales and adjusted earnings g
Henry Schein (NASDAQ:HSIC) reported second-quarter financial results on Tuesday. The transcript from the company's second-quarter earnings call has been provided below. This transcript is brought to you by Benzinga
Dental and medical products company Henry Schein (NASDAQ:HSIC) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 6.7% year ...
Dental and medical products company Henry Schein (NASDAQ:HSIC) will be reporting results this Tuesday before the bell. Here’s what you need to know. Henry Sc...
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...
While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor exec...
Wrapping up Q1 earnings, we look at the numbers and key takeaways for the dental equipment & technology stocks, including Henry Schein (NASDAQ:HSIC) and its ...
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does...
Henry Schein has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 7.2% to $81.6...
Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad t...
Henry Schein (NASDAQ:HSIC) executives said the company is on track with its 2026 commitments and value-creation plan, while pointing to continued momentum in the U.S. dental market despite broader concerns about consumer confidence.
Speaking at a Stifel dental track event moderated by Stifel Managi
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-...
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and...
Henry Schein (NASDAQ:HSIC) executives said the company is seeing continued momentum in its dental business and remains committed to previously outlined operating improvement targets, while acknowledging softness in medical tied to a weaker respiratory illness season.
Speaking at a Bank of America h
